Voting with Their Feet: Social Factors Linked with Treatment for Opioid Use Disorder Using Same-day Buprenorphine Delivered in California Hospitals

Overview

Journal Drug Alcohol Depend

Publisher Elsevier

Specialty Psychiatry

Date 2021 Mar 28

PMID 33773868

Citations 4

Authors

Mariah M Kalmin

David Goodman-Meza

Erik Anderson

Ariana Abid

Melissa Speener

Hannah Snyder

Arianna Campbell

Aimee Moulin

Steve Shoptaw

Andrew A Herring

Affiliations

Soon will be listed here.

Abstract

Background: Medication for opioid use disorder (MOUD) using buprenorphine in primary or specialty care settings is accessed primarily by persons with private health insurance, stable housing, and no polysubstance use. This paper applies Social Cognitive Theory to frame links between social factors and treatment outcomes among patients with social and economic disadvantages who are seeking MOUD at California Bridge Program (CA Bridge) hospitals.

Methods: Electronic medical records for patients identified with OUD between January-April, 2020 receiving care at CA Bridge hospitals defined outcomes: hospital-administered buprenorphine; provision of buprenorphine prescription at discharge. Multi-level models assessed whether social factors-housing status, insurance type, and co-methamphetamine use-predicted outcomes while accounting for group-level effects of treating hospital and controlling for age, race/ethnicity, and gender.

Results: 15 CA Bridge hospitals yielded 845 patient records. Most patients received hospital-administered buprenorphine (58 %) and/or a buprenorphine prescription (55 %); 26 % received neither treatment. Patients with unstable housing had greater odds of hospital-administered buprenorphine compared to patients with stable housing. Patients with Medicaid had greater odds of receiving a buprenorphine prescription compared to patients with other insurance. Co-methamphetamine use was not associated with outcomes.

Conclusions: Patients with OUD are successful in accessing same-day MOUD in CA Bridge hospital settings over a significant period. Importantly, access to MOUD in these settings was facilitated for patients traditionally not treated using buprenorphine, i.e., those with housing instability, Medicaid insurance, and co-methamphetamine use. Findings suggest barriers to MOUD for patients with social and economic disadvantages can be lowered by changing treatment delivery.

Citing Articles

Emergency Clinician Buprenorphine Initiation, Subsequent Prescriptions, and Continuous Prescriptions.

Dekker A, Schriger D, Herring A, Samuels E JAMA. 2025; .

PMID: 39969893 PMC: 11840682. DOI: 10.1001/jama.2024.27976.

Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review.

Bozinoff N, Grennell E, Soobiah C, Farhan Z, Rodak T, Bucago C Lancet Reg Health Am. 2024; 38:100899.

PMID: 39381082 PMC: 11459582. DOI: 10.1016/j.lana.2024.100899.

Disparities in Emergency Department Naloxone and Buprenorphine Initiation.

Papp J, Emerman C West J Emerg Med. 2023; 24(4):710-716.

PMID: 37527392 PMC: 10393464. DOI: 10.5811/westjem.58636.

Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers.

Stopka T, Rottapel R, Ferguson W, Pivovarova E, Toro-Mejias L, Friedmann P Int J Drug Policy. 2022; 110:103803.

PMID: 35965159 PMC: 10117037. DOI: 10.1016/j.drugpo.2022.103803.

High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder.

Herring A, Vosooghi A, Luftig J, Anderson E, Zhao X, Dziura J JAMA Netw Open. 2021; 4(7):e2117128.

PMID: 34264326 PMC: 8283555. DOI: 10.1001/jamanetworkopen.2021.17128.

References

Herring A, Perrone J, Nelson L . Managing Opioid Withdrawal in the Emergency Department With Buprenorphine. Ann Emerg Med. 2019; 73(5):481-487. DOI: 10.1016/j.annemergmed.2018.11.032. View

Krausz M, Jang K . North American opioid crisis: decline and fall of the war on drugs. Lancet Psychiatry. 2017; 5(1):6-8. DOI: 10.1016/S2215-0366(17)30479-0. View

Godersky M, Saxon A, Merrill J, Samet J, Simoni J, Tsui J . Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence. Addict Sci Clin Pract. 2019; 14(1):11. PMC: 6417248. DOI: 10.1186/s13722-019-0139-3. View

Wu L, Zhu H, Swartz M . Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016; 169:117-127. PMC: 5223737. DOI: 10.1016/j.drugalcdep.2016.10.015. View

Lee M, Schuur J, Zink B . Owning the cost of emergency medicine: beyond 2%. Ann Emerg Med. 2013; 62(5):498-505.e3. DOI: 10.1016/j.annemergmed.2013.03.029. View

Fahimi J, Goldfrank L . Principles of Social Emergency Medicine. Ann Emerg Med. 2019; 74(5S):S6-S10. DOI: 10.1016/j.annemergmed.2019.08.432. View

Duncan L, Mendoza S, Hansen H . Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers. J Addict Med Ther Sci. 2016; 1(2):31-36. PMC: 4830502. DOI: 10.17352/2455-3484.000008. View

Shover C, Falasinnu T, Dwyer C, Benitez Santos N, Cunningham N, Freedman R . Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance. Drug Alcohol Depend. 2020; 216:108314. PMC: 7521591. DOI: 10.1016/j.drugalcdep.2020.108314. View

Baggett T, Chang Y, Singer D, Porneala B, Gaeta J, OConnell J . Tobacco-, alcohol-, and drug-attributable deaths and their contribution to mortality disparities in a cohort of homeless adults in Boston. Am J Public Health. 2014; 105(6):1189-97. PMC: 4431083. DOI: 10.2105/AJPH.2014.302248. View

10.

Anderson E, Hsieh D, Alter H . Social Emergency Medicine: Embracing the Dual Role of the Emergency Department in Acute Care and Population Health. Ann Emerg Med. 2016; 68(1):21-5. DOI: 10.1016/j.annemergmed.2016.01.005. View

11.

Richardson L, Hwang U . Access to care: a review of the emergency medicine literature. Acad Emerg Med. 2001; 8(11):1030-6. DOI: 10.1111/j.1553-2712.2001.tb01111.x. View

12.

Rodriguez R, Fortman J, Chee C, Ng V, Poon D . Food, shelter and safety needs motivating homeless persons' visits to an urban emergency department. Ann Emerg Med. 2008; 53(5):598-602. DOI: 10.1016/j.annemergmed.2008.07.046. View

13.

Hansen H, Siegel C, Wanderling J, DiRocco D . Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City. Drug Alcohol Depend. 2016; 164:14-21. PMC: 5539992. DOI: 10.1016/j.drugalcdep.2016.03.028. View

14.

Carter J, Zevin B, Lum P . Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco. Addict Sci Clin Pract. 2019; 14(1):20. PMC: 6501460. DOI: 10.1186/s13722-019-0149-1. View

15.

Candon M, Zuckerman S, Wissoker D, Saloner B, Kenney G, Rhodes K . Declining Medicaid Fees and Primary Care Appointment Availability for New Medicaid Patients. JAMA Intern Med. 2017; 178(1):145-146. PMC: 5833510. DOI: 10.1001/jamainternmed.2017.6302. View

16.

Langendam M, van Brussel G, Coutinho R, van Ameijden E . The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health. 2001; 91(5):774-80. PMC: 1446673. DOI: 10.2105/ajph.91.5.774. View

17.

Williams R . The costs of visits to emergency departments. N Engl J Med. 1996; 334(10):642-6. DOI: 10.1056/NEJM199603073341007. View

18.

Williams A, Nunes E, Bisaga A, Levin F, Olfson M . Development of a Cascade of Care for responding to the opioid epidemic. Am J Drug Alcohol Abuse. 2019; 45(1):1-10. PMC: 6404749. DOI: 10.1080/00952990.2018.1546862. View

19.

Lagisetty P, Ross R, Bohnert A, Clay M, Maust D . Buprenorphine Treatment Divide by Race/Ethnicity and Payment. JAMA Psychiatry. 2019; 76(9):979-981. PMC: 6506898. DOI: 10.1001/jamapsychiatry.2019.0876. View

20.

DOnofrio G, McCormack R, Hawk K . Emergency Departments - A 24/7/365 Option for Combating the Opioid Crisis. N Engl J Med. 2018; 379(26):2487-2490. DOI: 10.1056/NEJMp1811988. View